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A model is presented for the binding of phospholipids and related molecules to membrane proteins, based 
on a fixed number of binding sites for fatty acyl chains. It is shown that in such a model, statistical factors 
favour binding of single chain molecules uch as fatty acids when present at low concentrations in mixtures 
with phospholipids 
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1. INTRODUCTION 
Both electron spin resonance (ESR) and fluor- 
escence techniques have been used to study the in- 
teractions of phospholipids and other hydrophobic 
molecules with membrane proteins and to obtain 
relative binding constants at the lipid-protein 
interface [l-8]. But it is unclear how the binding 
of phospholipids containing two fatty acyl chains 
(such as phosphatidylcholines) should be compared 
to the binding of a single chain molecule such as a 
fatty acid or to a lipid such as cardiolipin containing 
4 fatty acyl chains. Previously it has been assumed 
that all these molecules occupy a single site on the 
protein surface, but if the area of the lipid-protein 
interface is to be conserved, this seems intrinsically 
unlikely. A more reasonable model would be one 
in which a fixed number of fatty acyl chains are 
necessary to cover the hydrophobic protein surface 
so that fatty acids, phosphatidylcholines and car- 
diolipins will occupy, respectively, 1, 2 and 4 sites 
around the protein (fig.1). For such a model, 
binding can no longer be described by simple 
Scatchard analysis, for the following reasons. Con- 
sider an initial state in which all sites are occupied 
by fatty acids. If now a phospholipid is added that 
occupies two sites on the protein surface then the 
situation illustrated in fig.1 could develop. Ran- 
dom binding of the phospholipid could result in a 
single site being left unoccupied between two 
bound phospholipid molecules (as at A). Again, if 
binding of phospholipid molecules creates 3 con- 
secutive sites (as at B), then it is only possible for 
one phospholipid molecule to bind at these 3 sites. 
For statistical reasons of this kind, it becomes dif- 
ficult to completely saturate the sites with a multi- 
valent ligand such as a phospholipid. 
An exactly analogous problem arises in the study 
of ligand binding to pairs of sites on DNA, and has 
been analysed in [9]. We show here that the method 
of McGhee and von Hippel can be applied to our 
problem. 
2. THE MODEL 
We make a number of simplifying assumptions: 
Fig. 1. Binding sites on the surface of a membrane protein, 
showing 3 phospholipids bound at random, indicating 
the sites occupied by the l- and 2- fatty acyl chains. 
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(0 The lipid-protein interface consists of a fixed 
number Nof binding sites for fatty acyl chains, 
of equal affinity. 
(ii) The number of binding sites (N) is consider- 
ably greater than the number of adjacent sites 
(n) occupied by a particular ligand molecule. 
The system thus reduces to a linear lattice of 
N identical repeating binding sites in which 
end-effects can be ignored. 
(iii) Partial binding of a ligand is not allowed. 
Thus, for example, a phosphatidylcholine 
(n = 2) must occupy two fatty acyl sites. This 
assumption is justified below, but can be 
relaxed. 
(iv) Binding is non-cooperative. Cooperativity can 
be readily introduced [9], but there is insuffi- 
cient experimental data to make it presently 
worthwhile. 
We consider a protein in a membrane composed 
of a mixture of monovalent ligand L (e.g., fatty 
acid) and multivalent ligand L* (e.g., phosphati- 
dylcholine). Binding to the surface of the protein 
is described by a series of displacement reactions of 
the type: 
PL, + L* - PL* + FlL 
for which we can write an equilibrium constant K, 
K = [PL*] [L#/[PLn] [Lf*] (1) 
where: 
square brackets denote concentrations; 
[Lf] and [Lf] are the concentrations of unbound L 
and L* respectively. For convenience, we have 
used a nomenclature similar to that in [4] where it 
is shown that, when all L and L* are in the mem- 
brane (which will be true for very hydrophobic 
molecules), the natural unit for concentration and 
standard state is the mole fraction. 
The equilibrium constant can be rewritten in terms 
of the more usual concentration units of mol of 
ligand/l of medium: 
* n-l K = nL:L?/Lt,Lf(Lf + Lf ) 
where: 
(2) 
Lb and Lb* are the concentrations (mol/l) of L and 
L*, respectively bound to the protein; 
Lf and Lf* are the corresponding unbound concen- 
trations. 
From the various conservation relationships we 
have: 
binding sites: 
Lb + rlL: = NP (3) 
monovalent ligand: 
Lf $ Lb = Lt 
multivalent ligand: 
Lf*+Lb*=Lt* 
where P is the protein concentration. 
(4) 
(5) 
It has been shown [9] that in the description of 
the binding of a multivalent ligand, the free site 
concentration has to be multiplied by a factor P,,, 
giving the probability that a free site will be fol- 
lowed by at least n - 1 other free sites, thus allowing 
binding of a ligand of valence n. In our case, 
equations 2-5 can be readily combined to give an 
equation analogous to the Scatchard equation: 
1 (NP - nL:)P,, (6) 
Simple statistical arguments [9] give the probability 
factor P, as 
P,, = ((NP - nLt)/(NP - n - l)LE))“- ’ (7) 
Equation (6) assumes ‘stereochemical’ binding of 
the multivalent ligand: that is, the ligand can bind 
only one way round to the site. If this requirement 
is relaxed, then it can be shown that P,, is unaltered, 
but that K in equation (6) should be replaced by 2K 
to allow for the two statistical ways of binding. For 
monovalent ligands, Pn reduces to one, and equa- 
tion (6) has the form of the simple Scatchard 
equation as derived in [4]. For multivalent ligands, 
P,, is always less than unity, and as it is a function 
of Lb* it will give curved binding plots. The effect 
of the Pn term becomes large when Lb*/N is large. 
Unfortunately equation (6) cannot be written in 
a form which allows direct calculation of Lb*. How- 
ever, the equation can be readily solved for Lb* 
using numerical methods, such as the method of 
bisection [lo]. Again following [4] we define: 
x = LJP, x* = LT/P; 
y = Lf/(L - Lfh 
y* = LT/(Lt* - Lf*). 
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Fig. 2 and 3 compare calculated binding plots for 
mixtures of ligand of the same valence with those 
for mixtures of monovalent and divalent ligand. 
Calculated ratios of bilayer/bound divalent ligand 
in mixtures with a monovalent ligand are similar to 
calculated ratios of bilayer/bound monovalent 
ligand in mixtures of two monovalent ligand, when 
the relative binding constant K for the former is 
twice that of the latter (fig.2). Differences between 
the two sets of binding curves are greatest at high 
mol fractions of the divalent ligand, as expected. 
The two sets of curves become identical over 
intermediate concentration ranges if the relative 
concentrations of ligands are expressed on the 
basis of fatty acyl chain concentration (i.e., 1 phos- 
pholipid = 2 fatty acyl chains), and the factor of 
Oj I I I 
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Fig.2. Calculated ratios of bilayerjbound concentrations 
for a ligand L* in mixtures with a second ligand L, as a 
function of the ratio of the ligand L* to protein concen- 
tration, expressed as nx* where n is the number of sites 
occupied by the ligand I?.*. The number of binding/pro- 
tein, N = 40, and the ratio of the total concentrations of 
L* and L to protein concentration is maintained at 
x + nx* = 80. Each curve corresponds to the marked 
value of the relative binding constant K. Solid lines cor- 
respond to the case where both L* and L are monovalent 
ligands, so that n = 1. Broken lines correspond to the 
case where L* is a divalent ligand and L is a monovalent 
ligand, so that n = 2. The calculated curve for K = 2 and 
n = 2 is identical to that shown with K = 1 and n = 1. 
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Fig.3. Calculated ratios of bilayer/bound concentrations 
for a ligand L in mixtures with a second ligand L*, under 
the conditions given in the legend to fig.2. 
2 is introduced into the relative binding constant. 
Binding curves for monovalent ligand in mixtures 
with another monovalent ligand are very different 
from those for mixtures with a divalent ligand 
when the mixtures contain a high mol fraction of 
divalent ligand (fig.3). The curves reflect the diffi- 
culty in saturating the sites around the protein with 
divalent ligand, because of the statistical factor 
(equation (7)). This point is also clearly made in 
fig.4, which represents an experiment in which the 
concentration of monovalent ligand is kept con- 
stant at a low value, and the concentration of 
divalent ligand is increased. 
The overlapping site model presented here gives 
rise to a rather different interpretation of ESR data 
on the binding of spin-labelled compounds to 
membrane proteins. Table 1 illustrates this with 
some simulated data based on experiments with 
rhodospin [2]. Typically in ESR experiments, the 
spin-labelled derivative is present as a small frac- 
tion (1010) of the total lipid, to prevent line- 
broadening effects. Experiment A of table 1 repre- 
sents a measurement of the bilayer/bound ratio of 
a spin-labelled fatty acid in the presence of a two- 
chain phospholipid. If it is assumed that the fatty 
acid and phospholipid compete in a one-to-one 
fashion for sites on the protein (so that for both 
ligands n = 1) then, as expected, the bilayer/bound 
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Lpd/Roteln x* 
Fig.4. Calculated ratio of bilayer/bound concentrations 
for a fatty acid in mixtures with a phospholipid (n = 2), 
as a function of the phospholipid/protein ratio x*, for 
the marked values of the relative binding constants. The 
fatty acid/protein ratio was fixed at 1.0. Solid lines 
represent calculations based on a one-to-one displace- 
ment model, with the number of binding sites/protein 
N = 40. Broken lines represent calculations based on the 
overlapping site model, with the number of fatty acyl 
chain sites/protein N = 80. 
ratio for the fatty acid is linearly related to the 
binding constant for the phospholipid relative to 
that for the fatty acid (K). This simple relationship 
no longer holds if the phospholipid is assumed to 
occupy two sites on the protein, because statistical 
factors increase the probability that at least a few 
sites on the protein will be occupied by fatty acid. 
The problem no longer arises if the experiment is 
done the other way round, with the spin-labelled 
derivative being the multivalent ligand (experiment 
B, table 1). Binding constants derived from the two 
models simply differ by a factor of close to two, 
reflecting the requirement for two monovalent 
ligands to displace one divalent ligand in the over- 
lapping site model. 
The model presented here can be used to reinter- 
pret some published ESR experiments, as shown in 
table 2. For the experiments with cardiolipin spin 
labels, the binding constants in table 2 are about 
twice those calculated on the basis of one-to-one 
Table 1 
Calculated bilayer/bound molar ratios for a protein with 
N = 24, in which one ligand (ligand 1) is monovalent and 
the other is either monovalent or divalent 
Molar ratio Molar ratio Ligand 2 Ka Ligand 1 
Ligand 1 Ligand 2 
protein protein n=l n=2 
Bilayer 
bound 
A 0.65 65.0 0.6 0.1 1.0 
0.65 65.0 1.15 2.8 2.0 
0.65 65.0 1.75 6.0 3.0 
Ligand 2 
Bilayer 
bound 
B 65.0 0.65 1.67 0.70 1.0 
65.0 0.65 0.87 0.35 2.0 
65.0 0.65 0.57 0.23 3.0 
a Binding constant for ligand 2 relative to ligand 1 
displacement. However, there is no simple rela- 
tionship between the binding constants for fatty 
acid spin labels calculated on the basis of the two 
models. The calculated binding constants are in- 
sensitive to the assumed spin label concentration in 
this region. 
3. DISCUSSION 
Binding of phospholipids and fatty acyl deriva- 
tives to membrane proteins has been discussed in 
terms of a fixed number of fatty acyl chain binding 
sites on the hydrophobic surfaces of the protein. A 
statistical approach allows the calculation of the 
composition of the annulae around membrane pro- 
teins in the presence of mixtures of hydrophobic 
derivatives of different valence, such as fatty acids 
(n = 1) phosphatidylcholines (n = 2) and cardio- 
lipin (n = 4). The model predicts that in mixtures 
of phospholipid containing a low concentration of 
fatty acid, a relatively large fraction of the fatty 
acid will be bound to the protein, for statistical 
reasons. Absolute values of protein affinities for 
spin-labelled fatty acids made using ESR methods, 
will therefore tend to be overestimates. It is not 
possible to use high concentrations of spin label 
where statistical effects are less important because 
of line broadening effects. Measurements of rela- 
tive binding constants can, however, be made over 
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Table 2 
Binding parameters estimated from spin-label experiments 
January 1983 
Protein Ligand” Nb XC X *C Y b eIpf Y* b expt K,cld 
divalent/ 
monovalent 
Rhodopsin ICSASL 48 0.65 65.0 1.94 _ 2.5 
1CCLSL 24 65.0 0.65 _ 2.51 1.4 
Na/K-ATPase 1CSASL 116 3.0 305.0 2.57 - 0.6 
14-CLSL 58 305.0 3.0 _ 1.0 9.0 
a SASL, stearic acid spin label; CLSL, cardiolipin spin label 
b Taken from [2,3] 
’ Calculated assuming a spin label concentration of 1% of the total lipid concentration 
d Calculated assuming stereospecific binding 
a wider concentration range using fluorescence 
quenching techniques, and elsewhere we have 
shown that binding constants for fatty acids to the 
(Ca2+ -Mg2+)-ATPase can be obtained in this way 
171. 
In the above, analysis, the possibility of partial 
binding of the ligand to the protein surface has 
been discounted. Thus it has been assumed that 
when a phosphatidylcholine binds to the protein, 
both fatty acyl chains must occupy sites on the pro- 
tein, and binding of only one chain is now allowed. 
There are two reasons for thinking the assumption 
sound. Firstly, on binding to the protein surface, 
a molecule will lose much entropy (translational, 
rotational and conformational), and most of this 
loss will occur after the initial binding event. 
Binding of both fatty acyl chains of a phospholipid 
will therefore be favoured over binding of a single 
chain. Secondly, the unbound fatty acyl chain of a 
phospholipid attached to a protein by a single chain 
would be expected to have a mobility intermediate 
between that for a phospholipid fully bound to a 
protein and a phospholipid in a bilayer: no evidence 
for such an intermediate state has been reported 
[l-4]. 
Finally, our analysis has assumed a constant 
number of annular sites. That is, we have dis- 
counted the possibility of random protein-protein 
contacts which would result in a number of annular 
sites that would vary with protein concentration in 
the membrane. This might seem to be at variance 
with the generally low selectivity of the annular 
sites for phospholipids [2-61, since low selectivity 
suggests weak binding. However, the most impor- 
tant factor in determining the distribution of mole- 
cules in the membrane is the relative energies of 
protein-phospholipid and protein-protein inter- 
actions in the membrane [ll]. If random pro- 
tein-protein interactions are very unfavourable, 
then proteins will maintain a constant phospho- 
lipid annulus even if the protein-phospholipid 
interaction is weak. Specific protein-protein inter- 
actions may, of course, be strong, leading to 
specific oligomerisation, with a phospholipid an- 
nulus then surrounding the oligomer. 
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